HR 1117 · 119th CongressIn Committeecongress.gov ↗
What this bill does
AI plain-language summaryThis bill would ban drug companies from advertising new prescription drugs directly to consumers for the first three years after the FDA approves them. This includes ads on social media. The FDA could allow advertising in the third year if it decides the ads would help public health, or it could extend the ban beyond three years if studies show the drug causes serious health problems. The rule would apply to drugs approved starting one year before this bill becomes law.
Your Vote
Discussion (0)
Explain what is at stake in this bill.
Sign in to join the discussion.
No comments yet. Be the first.